• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

N1-甲基腺苷(mA)在 ND5 mRNA 中的甲基化导致阿尔茨海默病中复合物 I 功能障碍。

N1-methylation of adenosine (mA) in ND5 mRNA leads to complex I dysfunction in Alzheimer's disease.

机构信息

Institute of Pharmaceutical and Biomedical Sciences, Johannes Gutenberg-University Mainz, Staudingerweg 5, 55128, Mainz, Germany.

Institute of Molecular Medicine, University Medical Center Mainz, Langenbeckstr. 1, 55131, Mainz, Germany.

出版信息

Mol Psychiatry. 2024 May;29(5):1427-1439. doi: 10.1038/s41380-024-02421-y. Epub 2024 Jan 29.

DOI:10.1038/s41380-024-02421-y
PMID:38287100
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11189808/
Abstract

One mechanism of particular interest to regulate mRNA fate post-transcriptionally is mRNA modification. Especially the extent of mA mRNA methylation is highly discussed due to methodological differences. However, one single mA site in mitochondrial ND5 mRNA was unanimously reported by different groups. ND5 is a subunit of complex I of the respiratory chain. It is considered essential for the coupling of oxidation and proton transport. Here we demonstrate that this mA site might be involved in the pathophysiology of Alzheimer's disease (AD). One of the pathological hallmarks of this neurodegenerative disease is mitochondrial dysfunction, mainly induced by Amyloid β (Aβ). Aβ mainly disturbs functions of complex I and IV of the respiratory chain. However, the molecular mechanism of complex I dysfunction is still not fully understood. We found enhanced mA methylation of ND5 mRNA in an AD cell model as well as in AD patients. Formation of this mA methylation is catalyzed by increased TRMT10C protein levels, leading to translation repression of ND5. As a consequence, here demonstrated for the first time, TRMT10C induced mA methylation of ND5 mRNA leads to mitochondrial dysfunction. Our findings suggest that this newly identified mechanism might be involved in Aβ-induced mitochondrial dysfunction.

摘要

一个特别引起人们关注的调节 mRNA 命运的机制是 mRNA 修饰。由于方法学上的差异,m6A mRNA 甲基化的程度受到了高度的讨论。然而,不同的研究小组一致报道了线粒体 ND5 mRNA 上的一个单一的 m6A 位点。ND5 是呼吸链复合物 I 的一个亚基。它被认为对氧化和质子运输的偶联是必不可少的。在这里,我们证明了这个 m6A 位点可能与阿尔茨海默病(AD)的病理生理学有关。这种神经退行性疾病的病理标志之一是线粒体功能障碍,主要是由淀粉样β(Aβ)引起的。Aβ主要干扰呼吸链复合物 I 和 IV 的功能。然而,复合物 I 功能障碍的分子机制仍不完全清楚。我们在 AD 细胞模型以及 AD 患者中发现 ND5 mRNA 的 m6A 甲基化增强。这种 m6A 甲基化的形成是由 TRMT10C 蛋白水平的增加催化的,导致 ND5 的翻译抑制。因此,我们首次证明,TRMT10C 诱导的 ND5 mRNA 的 m6A 甲基化导致线粒体功能障碍。我们的研究结果表明,这种新发现的机制可能与 Aβ 诱导的线粒体功能障碍有关。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b849/11189808/3bb2ba446b25/41380_2024_2421_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b849/11189808/0458d5424c87/41380_2024_2421_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b849/11189808/201e5c676bc7/41380_2024_2421_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b849/11189808/22af595fba4e/41380_2024_2421_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b849/11189808/48b06af87762/41380_2024_2421_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b849/11189808/8e048c00eb92/41380_2024_2421_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b849/11189808/3bb2ba446b25/41380_2024_2421_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b849/11189808/0458d5424c87/41380_2024_2421_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b849/11189808/201e5c676bc7/41380_2024_2421_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b849/11189808/22af595fba4e/41380_2024_2421_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b849/11189808/48b06af87762/41380_2024_2421_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b849/11189808/8e048c00eb92/41380_2024_2421_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b849/11189808/3bb2ba446b25/41380_2024_2421_Fig6_HTML.jpg

相似文献

1
N1-methylation of adenosine (mA) in ND5 mRNA leads to complex I dysfunction in Alzheimer's disease.N1-甲基腺苷(mA)在 ND5 mRNA 中的甲基化导致阿尔茨海默病中复合物 I 功能障碍。
Mol Psychiatry. 2024 May;29(5):1427-1439. doi: 10.1038/s41380-024-02421-y. Epub 2024 Jan 29.
2
The m1A landscape on cytosolic and mitochondrial mRNA at single-base resolution.单碱基分辨率下细胞质和线粒体 mRNA 上的 m1A 图谱。
Nature. 2017 Nov 9;551(7679):251-255. doi: 10.1038/nature24456. Epub 2017 Oct 25.
3
Impaired Cellular Bioenergetics Causes Mitochondrial Calcium Handling Defects in MT-ND5 Mutant Cybrids.细胞生物能量学受损导致MT-ND5突变体胞质杂种中线粒体钙处理缺陷。
PLoS One. 2016 Apr 25;11(4):e0154371. doi: 10.1371/journal.pone.0154371. eCollection 2016.
4
Impact of Amyloid-β on Platelet Mitochondrial Function and Platelet-Mediated Amyloid Aggregation in Alzheimer's Disease.淀粉样蛋白-β对阿尔茨海默病血小板线粒体功能和血小板介导的淀粉样蛋白聚集的影响。
Int J Mol Sci. 2021 Sep 6;22(17):9633. doi: 10.3390/ijms22179633.
5
Upregulation of human mitochondrial NADH dehydrogenase subunit 5 in intestinal epithelial cells is modulated by Vibrio cholerae pathogenesis.霍乱弧菌致病机制可调节人肠上皮细胞中线粒体NADH脱氢酶亚基5的上调。
FEBS Lett. 2005 Jun 20;579(16):3449-60. doi: 10.1016/j.febslet.2005.05.012.
6
The mA methyltransferase METTL3 modifies PGC-1α mRNA promoting mitochondrial dysfunction and oxLDL-induced inflammation in monocytes.m6A 甲基转移酶 METTL3 修饰 PGC-1α mRNA,促进单核细胞中线粒体功能障碍和 oxLDL 诱导的炎症。
J Biol Chem. 2021 Sep;297(3):101058. doi: 10.1016/j.jbc.2021.101058. Epub 2021 Aug 8.
7
MH84 improves mitochondrial dysfunction in a mouse model of early Alzheimer's disease.MH84 改善了早发性阿尔茨海默病小鼠模型的线粒体功能障碍。
Alzheimers Res Ther. 2018 Feb 13;10(1):18. doi: 10.1186/s13195-018-0342-6.
8
Amyloid-beta leads to impaired cellular respiration, energy production and mitochondrial electron chain complex activities in human neuroblastoma cells.β-淀粉样蛋白会导致人类神经母细胞瘤细胞中的细胞呼吸、能量产生及线粒体电子传递链复合体活性受损。
Cell Mol Neurobiol. 2009 Sep;29(6-7):1063-71. doi: 10.1007/s10571-009-9398-y. Epub 2009 Apr 7.
9
Differential expression of oxidative phosphorylation genes in patients with Alzheimer's disease: implications for early mitochondrial dysfunction and oxidative damage.阿尔茨海默病患者氧化磷酸化基因的差异表达:对早期线粒体功能障碍和氧化损伤的影响
Neuromolecular Med. 2004;5(2):147-62. doi: 10.1385/NMM:5:2:147.
10
Expression of the alternative oxidase mitigates beta-amyloid production and toxicity in model systems.交替氧化酶的表达减轻了模型系统中β-淀粉样蛋白的产生和毒性。
Free Radic Biol Med. 2016 Jul;96:57-66. doi: 10.1016/j.freeradbiomed.2016.04.006. Epub 2016 Apr 14.

引用本文的文献

1
ModiDeC: a multi-RNA modification classifier for direct nanopore sequencing.ModiDeC:一种用于直接纳米孔测序的多RNA修饰分类器。
Nucleic Acids Res. 2025 Jul 19;53(14). doi: 10.1093/nar/gkaf673.
2
Feedback regulation between histone lactylation and ALKBH3-mediated glycolysis regulates age-related macular degeneration pathology.组蛋白乳酰化与ALKBH3介导的糖酵解之间的反馈调节调控年龄相关性黄斑变性的病理过程。
Proc Natl Acad Sci U S A. 2025 Jun 17;122(24):e2416046122. doi: 10.1073/pnas.2416046122. Epub 2025 Jun 10.
3
Metabolic Markers Demonstrate the Heterogeneity of Walking Ability in Non-Disabled Community-Dwelling Older Adults.

本文引用的文献

1
Coordination of RNA modifications in the brain and beyond.大脑及其他部位RNA修饰的协调。
Mol Psychiatry. 2023 Jul;28(7):2737-2749. doi: 10.1038/s41380-023-02083-2. Epub 2023 May 3.
2
If amyloid drives Alzheimer disease, why have anti-amyloid therapies not yet slowed cognitive decline?如果淀粉样蛋白驱动阿尔茨海默病,为什么抗淀粉样蛋白疗法尚未减缓认知能力下降?
PLoS Biol. 2022 Jul 21;20(7):e3001694. doi: 10.1371/journal.pbio.3001694. eCollection 2022 Jul.
3
mA RNA Modification in Gene Expression Regulation.mRNA 修饰在基因表达调控中的作用。
代谢标志物揭示了非残疾社区居住老年人行走能力的异质性。
Metabolites. 2025 May 19;15(5):334. doi: 10.3390/metabo15050334.
4
The RMaP challenge of predicting RNA modifications by nanopore sequencing.通过纳米孔测序预测RNA修饰的RMaP挑战。
Commun Chem. 2025 Apr 12;8(1):115. doi: 10.1038/s42004-025-01507-0.
5
Analysis of human brain RNA-seq data reveals combined effects of 4 types of RNA modifications and 18 types of programmed cell death on Alzheimer's disease.对人类大脑RNA测序数据的分析揭示了4种RNA修饰和18种程序性细胞死亡对阿尔茨海默病的联合作用。
J Transl Med. 2025 Apr 3;23(1):396. doi: 10.1186/s12967-025-06324-6.
6
The Secret Life of N-methyladenosine: A Review on its Regulatory Functions.N-甲基腺苷的隐秘生活:关于其调控功能的综述
J Mol Biol. 2025 Aug 15;437(16):169099. doi: 10.1016/j.jmb.2025.169099. Epub 2025 Mar 24.
7
RNA modifications in cancer.癌症中的RNA修饰
MedComm (2020). 2025 Jan 10;6(1):e70042. doi: 10.1002/mco2.70042. eCollection 2025 Jan.
8
Chronological Dynamics of Neuroinflammatory Responses in a High-Fat Diet Mouse Model.高脂饮食小鼠模型中神经炎症反应的时间动态变化
Int J Mol Sci. 2024 Nov 29;25(23):12834. doi: 10.3390/ijms252312834.
9
Epigenetics-targeted drugs: current paradigms and future challenges.表观遗传学靶向药物:当前范例与未来挑战。
Signal Transduct Target Ther. 2024 Nov 26;9(1):332. doi: 10.1038/s41392-024-02039-0.
10
Post-Translational Modifications of RNA-Modifying Proteins in Cellular Dynamics and Disease Progression.RNA 修饰蛋白的翻译后修饰在细胞动态和疾病进展中的作用。
Adv Sci (Weinh). 2024 Nov;11(44):e2406318. doi: 10.1002/advs.202406318. Epub 2024 Oct 8.
Genes (Basel). 2022 May 19;13(5):910. doi: 10.3390/genes13050910.
4
RNA nucleotide methylation: 2021 update.RNA 核苷酸甲基化:2021 年更新。
Wiley Interdiscip Rev RNA. 2022 Jan;13(1):e1691. doi: 10.1002/wrna.1691. Epub 2021 Dec 15.
5
MODOMICS: a database of RNA modification pathways. 2021 update.MODOMICS:RNA 修饰途径数据库。2021 年更新。
Nucleic Acids Res. 2022 Jan 7;50(D1):D231-D235. doi: 10.1093/nar/gkab1083.
6
Mitochondrial Dysfunction as a Causative Factor in Alzheimer's Disease-Spectrum Disorders: Lymphocytes as a Window to the Brain.线粒体功能障碍作为阿尔茨海默病谱系障碍的致病因素:淋巴细胞作为通向大脑的窗口。
Curr Alzheimer Res. 2021;18(10):733-752. doi: 10.2174/1567205018666211208141512.
7
The case for low-level BACE1 inhibition for the prevention of Alzheimer disease.用于预防阿尔茨海默病的低水平 BACE1 抑制作用。
Nat Rev Neurol. 2021 Nov;17(11):703-714. doi: 10.1038/s41582-021-00545-1. Epub 2021 Sep 21.
8
Structural basis of RNA processing by human mitochondrial RNase P.人线粒体核糖核酸酶 P 进行 RNA 加工的结构基础。
Nat Struct Mol Biol. 2021 Sep;28(9):713-723. doi: 10.1038/s41594-021-00637-y. Epub 2021 Sep 6.
9
The Antibiotic Doxycycline Impairs Cardiac Mitochondrial and Contractile Function.多西环素抗生素损害心肌线粒体和收缩功能。
Int J Mol Sci. 2021 Apr 15;22(8):4100. doi: 10.3390/ijms22084100.
10
Mitochondrial complex I abnormalities is associated with tau and clinical symptoms in mild Alzheimer's disease.线粒体复合物 I 异常与轻度阿尔茨海默病中的 tau 蛋白和临床症状有关。
Mol Neurodegener. 2021 Apr 26;16(1):28. doi: 10.1186/s13024-021-00448-1.